12:00 AM
Jan 28, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

KV Pharmaceutical, Perrigo sales and marketing update

KV's Ther-Rx Corp. subsidiary and Perrigo relaunched Gynazole-1 butoconazole nitrate vaginal cream in the U.S. to treat vulvovaginal candidiasis infections caused by Candida. The...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >